Amanote Research

Amanote Research

    RegisterSign In

Anti-Proliferative Therapy for HIV Cure: A Compound Interest Approach

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-04160-3
Full Text
Open PDF
Abstract

Available in full text

Categories
Multidisciplinary
Date

June 21, 2017

Authors
Daniel B. ReevesElizabeth R. DukeSean M. HughesMartin PrlicFlorian HladikJoshua T. Schiffer
Publisher

Springer Science and Business Media LLC


Related search

Development of HIV Vectors for Anti-Hiv Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

A Cure for HIV: How Would We Know?

The Lancet HIV
EpidemiologyInfectious DiseasesImmunologyVirology
2020English

AstraZeneca's Compound Interest

Science-Business eXchange
2012English

HIV Latency Reversal Agents: Effective for Cure?

HIV: Current Research
2018English

Conditional Cytotoxic Anti-Hiv Gene Therapy for Selectable Cell Modification

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2016English

Anti-Retroviral Therapy of Hiv Infected Patients

Journal of the University of Malaya Medical Centre
Medicine
2014English

MRN-100, an Iron-Based Compound, Possesses Anti-Hiv ActivityIn Vitro

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2010English

Laser or Anti‐VEGF for Proliferative Diabetic Retinopathy

Acta Ophthalmologica
MedicineOphthalmology
2018English

Can Immunotherapy Be Useful for a « Functional Cure » of HIV Infection?

Retrovirology
VirologyInfectious Diseases
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy